|
⚲
|
| Keyboard |
| Hirsch Andrew
✚
|
|
|---|---|
| CIK # | 0001586707 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001586707] | |
| 4 | [0001586707] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hirsch Andrew | |
| Editas Medicine Inc | |
| C4 Therapeutics Inc | |
| Agios Pharmaceuticals Inc | |
| DNIB Unwind Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-15 | Tax withheld | 9,057 | $1.89 | 17,118 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-15 | Option exercise | 20,400 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Tax withheld | 39,154 | $1.89 | 74,001 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Option exercise | 81,725 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Grant | 700,000 | $0.00 | |
|
Editas Medicine Inc EDIT
Stock Option (right to buy) · derivative
|
2025-06-06 | Grant | 37,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-15 | Tax withheld | 9,370 | $3.18 | 29,797 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 335,300 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Grant | 223,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Tax withheld | 12,847 | $3.18 | 40,853 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Tax withheld | 5,550 | $6.04 | 33,522 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Option exercise | 12,500 | ||
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-11-07 | Option exercise | 12,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Tax withheld | 3,329 | $6.36 | 21,172 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Option exercise | 7,500 | ||
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-09-16 | Option exercise | 7,500 | $0.00 | |
|
Editas Medicine Inc EDIT
Stock Option (right to buy) · derivative
|
2024-05-30 | Grant | 25,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-02-15 | Tax withheld | 6,560 | $7.90 | 51,824 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-02-14 | Grant | 103,400 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-02-14 | Grant | 465,500 | $0.00 | |
| showing 20 of 72 most recent transactions | |||||